Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer
Open Access
- 28 February 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (2), e243
- https://doi.org/10.1371/journal.pone.0000243
Abstract
The urokinase plasminogen activator (uPA) and its receptor (uPAR/CD87) are major regulators of extracellular matrix degradation and are involved in cell migration and invasion under physiological and pathological conditions. The uPA/uPAR system has been of great interest in cancer research because it is involved in the development of most invasive cancer phenotypes and is a strong predictor of poor patient survival. However, little is known about the role of uPA/uPAR in small cell lung cancer (SCLC), the most aggressive type of lung cancer. We therefore determined whether uPA and uPAR are involved in generation of drug resistant SCLC cell phenotype. We screened six human SCLC cell lines for surface markers for putative stem and cancer cells. We used fluorescence-activated cell sorting (FACS), fluorescence microscopy and clonogenic assays to demonstrate uPAR expression in a subpopulation of cells derived from primary and metastatic SCLC cell lines. Cytotoxic assays were used to determine the sensitivity of uPAR-positive and uPAR-negative cells to chemotherapeutic agents. The uPAR-positive cells in all SCLC lines demonstrated multi-drug resistance, high clonogenic activity and co-expression of CD44 and MDR1, putative cancer stem cell markers. These data suggest that uPAR-positive cells may define a functionally important population of cancer cells in SCLC, which are resistant to traditional chemotherapies, and could serve as critical targets for more effective therapeutic interventions in SCLC.Keywords
This publication has 36 references indexed in Scilit:
- Targeting of CD44 eradicates human acute myeloid leukemic stem cellsNature Medicine, 2006
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?Thrombosis and Haemostasis, 2005
- Identification of human brain tumour initiating cellsNature, 2004
- Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human GlioblastomaCancer Research, 2004
- CD44 Potentiates the Adherence of Metastatic Prostate and Breast Cancer Cells to Bone Marrow Endothelial CellsCancer Research, 2004
- Urokinase-Type Plasminogen Activator System in Breast CancerCancer Research, 2004
- Hyaluronan: from extracellular glue to pericellular cueNature Reviews Cancer, 2004
- Small cell lung cancer: from molecular biology to novel therapeuticsJournal of Experimental Therapeutics and Oncology, 2003
- Deregulation of the signaling pathways controlling urokinase productionEuropean Journal of Biochemistry, 1999